A study has found that weight-loss drugs, specifically GLP-1 medications, may be linked to a lower risk of breast cancer. The research suggests a potential association between the use of these drugs and reduced breast cancer incidence. The extent of the risk reduction is reported to be as high as 30% lower in some cases, although the details and implications of the findings are still being explored.